ScholarIQanswers from OpenAlex & ORCID
Tiago Torres
ResearcherPublications, citations & collaboration network
Tiago Torres is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Tiago Torres have?
ScholarIQindexed works
Tiago Torres has 349 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Tiago Torres have?
ScholarIQcitation count
Tiago Torres has 5,671 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Tiago Torres?
ScholarIQh-index
Tiago Torres has an h-index of 42 in OpenAlex.
What is the i10-index of Tiago Torres?
ScholarIQi10-index
Tiago Torres has an i10-index of 139 in OpenAlex.
What is the ORCID of Tiago Torres?
ScholarIQorcid
The ORCID for Tiago Torres is on the source record.
What is the OpenAlex record for Tiago Torres?
ScholarIQopenalex
The OpenAlex for Tiago Torres is on the source record.
What are the most-cited papers on Tiago Torres?
ScholarIQmost cited works
Update on Atopic Dermatitis
Tiago Torres, Eduarda Osório Ferreira, Margarida Gonçalo, Pedro Mendes‐Bastos, Manuela Selores, Paulo Filipe
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
Satveer K. Mahil, Nick Dand, K.J. Mason, Zenas Z N Yiu, Teresa Tsakok, Freya Meynell, Bola Coker, Helen McAteer, Lucy Moorhead, Teena Mackenzie, Mariateresa Rossi, R. Rivera, E. Mahé, Andrea Carugno, Michela Magnano, Giulia Rech, Esther A. Balogh, Steven R. Feldman, Claudia De La Cruz, Siew Eng Choon, Luigi Naldi, Jo Lambert, Phyllis I. Spuls, D. Jullien, H. Bachelez, Devon E. McMahon, Esther E. Freeman, Paolo Gisondi, L. Puig, Richard B. Warren, Paola Di Meglio, Sinéad Langan, Francesca Capon, C.E.M. Griffiths, Jonathan N. Barker, Catherine Smith, Aadarsh Shah, Alberto Barea, Alberto Romero‐Maté, Alekya Singapore, Alexandra Paolino, Alice Mwale, Ana Maria Morales Callaghan, A. J. Martinez, Andrew J. DeCrescenzo, Andrew Pink, Ann Jones, Ann Sergeant, Annette Essex, Anthony Bewley, Areti Makrygeorgou, Astrid M. van Huizen, Beatriz Pérez‐Suárez, Farida Benhadou, Birgitta Wilson Claréus, Carla Tubau Prims, Carrie L. Davis, Catherine Quinlan, Catriona Maybury, Gonzalez A. Cesar, Charlotte Barclay, Claudio Greco, Danielle Brassard, Deanna Cummings, Deepti Kolli, V. Descamps, Diana Ruíz Genao, Efrossini Carras, Elena B. Hawryluk, Eliseo Martínez‐García, Elżbieta Kłujszo, Emily Dwyer, Emmanuel Toni, Enikö Sonkoly, Enrique Loayza, E. Daudén, Fernando Valenzuela, G Popov, Georgie King, Girard Celine, Gloria Aparicio, Graham A.R. Johnston, Gustavo Anibal Cardozo, Ian Pearson, I. Yanguas, Jamie Weisman, Jennifer E. Carolan, Jenny Hughes, José María Ortiz Salvador, J.M. Carrascosa, Joseph J. Schwartz, Karina Jackson, Kathryn G. Kerisit, K. Wu, Leila Asfour, Leontien de Graaf, Cécile Lesort, L. Meuleman, Liv Eidsmo, Lone Skov
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Miguel Nogueira, L. Puig, Tiago Torres
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
Sandra Ferreira, Emma Guttman‐Yassky, Tiago Torres
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
Tiago Torres, L. Puig, Ronald Vender, Charles Lynde, Stefano Piaserico, J.M. Carrascosa, Paolo Gisondi, E. Daudén, Curdin Conrad, Pedro Mendes‐Bastos, Paulo Ferreira, Luíz Leite, Justin D. Lu, Joana Valério, Manfredo Bruni, Francesco Messina, Alessia Nidegger, Mar Llamas‐Velasco, E. del Alcázar, Asfandyar Mufti, Kyra White, Giacomo Caldarola, Laetitia Teixeira, Paolo Romanelli, K. Desai, Spyridon Gkalpakiotis, Marco Romanelli, Jensen Yeung, Miguel Nogueira, Andrea Chiricozzi